Cost-Effectiveness Analysis of Sunitinib Versus Interferon Alfa for the First-Line Treatment of Advanced And/Or Metastatic Renal Cell Carcinoma in Singapore
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.110
https://www.valueinhealthjournal.com/article/S1098-3015(18)32467-7/fulltext
Title :
Cost-Effectiveness Analysis of Sunitinib Versus Interferon Alfa for the First-Line Treatment of Advanced And/Or Metastatic Renal Cell Carcinoma in Singapore
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32467-7&doi=10.1016/j.jval.2018.07.110
First page :
Section Title :
Open access? :
No
Section Order :
119